extra beer margin compens
messag maintain cautiou view stock given continu
deceler beer busi signific risk associ canopi
invest today earn ahead expect beer deplet
soft manag narrow beer growth guidanc low end
previou target rang adjust ep estim
 prev account beat quarter
extra quarter wine busi partial off-set higher tax rate lower
canopi earn increas price target prev
constel report organ sale growth ahead estim
due better wine shipment partial off-set lower beer volum beer shipment volum
estim gener line deplet adjust ep
ahead exclud constel share canopi earn
subtract benefit lower tax rate revers
manag increas ep guidanc rang
reflect stronger beer margin addit quarter earn wine brand
pend divestitur off-set partial higher annual tax rate estim
addit quarter earn worth roughli ep off-set higher interest
due delay repay debt divestitur proce bearish thesi remain
unchang given growth beer portfolio deceler year transit
wine segment specul invest canopi make stock significantli
riskier opinion
beer deceler beer segment deceler year-to-d deplet
versu last year innov arent offset slowdown modelo remain
healthi grower corona brand famili continu slow premier familiar fail
drive increment portfolio addit dont expect refresca upcom
launch corona seltzer fill gap expect launch seltzer creat
nois due initi trial think difficult constel take meaning
share categori domin two establish brand model
organ sale growth estim high end revis guidanc rang
go
right thing wine view year transit believ
compani still need carri multipl off-strategi brand portfolio indefinit see
note compani expect divis achiev mid-singl digit organ sale
growth follow divestitur next year driven bp volum
bp price mix bp contribut innov
think achiev path mostli price mix innov
plu seem aspir given relianc volum growth outpac industri
organ sale segment declin gs pt price
mix believ primari unknown next year implement risk
price increas woodbridg effect appli beer market strategi
wine histor consum push categori
believ canopi remain biggest risk remain skeptic canopi
invest outsid constel core compet clear path gener
meaning return near term opinion one primari concern dont
think investor fulli discount risk associ us fda highlight
concern fda said novemb cbd potenti caus harm
issu warn letter compani illeg sell cannabidiol product base
consensu estim constel share canopi earn
subtract prev
page analyst certif import disclosur
valuat risk
prev price target base blend multipl discount
earn estim ev ebitda chang multipl
rel histori think stock merit discount pe trade
past year given higher level risk follow invest canopi growth
weed pronounc deceler beer segment immedi
point inflect
risk upsid given valuat neutral rate
better expect perform new innov includ corona premier
corona familiar littl cannib core corona busi
continu expans corona modelo acv beyond think variou
packag format achiev
feder legal marijuana us success expans new
innov canopi growth
risk downsid given valuat neutral rate
corona premier familiar continu cannib corona franchis
rapid pace expect corona extra declin worsen
canopi invest provid higher earlier expect return rapid
legal recreat marijuana us
corona refresca fail add increment growth overal corona franchis
page analyst certif import disclosur
page analyst certif import disclosur
incom million except per emay excis gross net y-o-i growth cost good gross gross sell gener expens total oper sg oper oper y-o-i growth equity-method canopi ebitda y-o-i growth net interest expens pre-tax incom tax non-control net incom adj dilut ep incl y-o-i growth ep ex y-o-i growth dilut share sale price acquisit extra week net sale organ beverag
issu research report guggenheim secur llc guggenheim secur research analyst whose name appear report
herebi certifi view express report accur reflect research analyst person view subject
secur issuer discuss herein ii part research analyst compens directli indirectli relat specif
recommend view express research analyst
research analyst research associ receiv compens base upon variou factor includ qualiti research investor client
feedback guggenheim secur llc overal revenu includ invest bank revenu
guggenheim secur llc affili expect receiv intend seek compens invest bank servic constel
inc next month
pleas refer websit company-specif disclosur referenc report http //guggenheimsecur bluematrix com/sellside/
disclosur action disclosur inform also avail complianc madison avenu new york ny
rate price target histori constel inc
creat bluematrix
buy describ stock expect provid total return price appreci plu yield within period
neutral describ stock expect provid total return price appreci plu yield plu minu within
sell describ stock expect provid total neg return price appreci plu yield within period
nr invest rate price target temporarili suspend suspens complianc applic regul and/or
cs coverag suspend guggenheim secur llc suspend coverag compani
nc cover guggenheim secur llc cover compani
monitor describ stock whose compani fundament financi monitor financi project opinion
invest merit compani provid
review ur follow releas signific news compani rate temporarili place review suffici
inform obtain assess analyst
guggenheim secur llc methodolog assign rate may includ follow market capit matur growth/valu volatil
expect total return next month price target base sever methodolog may includ restrict analys
market risk growth rate revenu stream discount cash flow dcf ebitda ep cash flow cf free cash flow ev/ebitda price-to-earnings pe/growth
price-to-cf p/fcf premium discount /averag group ev/ebitda premium discount /averag group price-to-earnings sum part net asset valu dividend return
return equiti roe next month
price target assign buy- sell-rat stock price target neutral-r stock provid discret analyst
page analyst certif import disclosur
